Business
Kenvue Releases Second Annual Healthy Lives Mission Report Highlighting Progress in Reducing Emissions and Advancing More Sustainable Product Innovation
Company reports reduction of operational emissions by 37%, expanded use of renewable electricity to 72% and launch of multiple packaging innovations across portfolio NORTHAMPTON, MA / ACCESS Newswire / June 26, 2025 / Kenvue Inc. (NYSE:KVUE), maker ...
About this update from Kenvue Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"Company reports reduction of operational emissions by 37%, expanded use of renewable electricity to 72% and launch of multiple packaging innovations across portfolio","length":165,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":165,"olType":false},{"type":"text","content":"NORTHAMPTON, MA / ACCESS Newswire / June 26, 2025 / Kenvue Inc. (NYSE:KVUE), maker of iconic brands such as Neutrogena®, Listerine®, Aveeno®, and Tylenol®, today released its second Healthy Lives Mission Report. The report shares how Kenvue has helped advance the well-being of both people and planet in 2024, with progress noted across three pillars: Healthy People, Healthy Planet, and Healthy Practice.","length":405,"tagName":"p"},{"type":"text","content":""Having some of the most recognizable consumer brands in the world gives us a tremendous opportunity to create a positive impact for the millions of people we touch every day," said Thibaut Mongon, Chief Executive Officer, Kenvue. "Whether improving our packaging to be more sustainable, advancing the decarbonization of our operations, or giving back to our communities, our sustainability strategy is helping meet customer and consumer expectations, and deliver everyday care for generations to come."","length":523,"tagName":"p"},{"type":"text","content":"Since becoming an independent company in 2023, Kenvue has invested in research and development, hired experts in areas like packaging, embedded sustainability into key functions and designed a sustainability strategy purposefully built to meet critical commitments and deliver superior consumer experiences and products.","length":320,"tagName":"p"},{"type":"text","content":"Highlights from the report include:","length":35,"tagName":"p"},{"type":"text","content":"Healthy People:","length":15,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Nicorette® QuickMist became the first nicotine replacement therapy (NRT) in the U.K. to be licensed to help vapers quit, with this vaping cessation indication now included across the whole Nicorette® range in the U.K.","length":217,"tagName":"p"}]},{"val":[{"type":"text","content":"Helped train health care professionals (HCPs) in Malaysia on the use of NRT solutions like Nicorette® and worked with the Health Minister of Malaysia to launch...